L627-1099 Screening compound: N-[1-(4-fluorophenyl)ethyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

Chemical Structure Depiction of ChemDiv screening compound L627-1099
N-[1-(4-fluorophenyl)ethyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

Available from 1 mg

Formats:

Glass Vials (4ml Glass Vials VWR #97047-678)
96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Check Price and Availability

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L627-1099

Molecular Formula

C₂₈H₃₂FN₅O₂ (C28 H32 FN5 O2)

Compound Name

N-[1-(4-fluorophenyl)ethyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

IUPAC name

N-[1-(4-fluorophenyl)ethyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]methyl}benzamide

SMILES

CC(c(cc1)ccc1F)NC(c1ccc(CN(CC2)Cc3c2n(C)nc3C(N2CCCC2)=O)cc1)=O

InChI

InChI=1S/C28H32FN5O2/c1-19(21-9-11-23(29)12-10-21)30-27(35)22-7-5-20(6-8-22)17-33-16-13-25-24(18-33)26(31-32(25)2)28(36)34-14-3-4-15-34/h5-12,19H,3-4,13-18H2,1-2H3,(H,30,35)/t19-/m0/s1

InChI Key

NBOKUDCJKJAZRE-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27466135

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

489.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

Partition Coefficient, logP

2.556

Distribution Coefficient, logD

-3.764

Water Solubility, LogSw

-2.79

Polar Surface Area

59.241

Acid Dissociation Constant (pK_a)

11.15

Base Dissociation Constant (pK_b)

13.72

Number of Chiral Centers

1.00

Percent sp³ carbon bonding

39.30

L627-1099 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Structure:

Therapeutical areas:

Cancer
Infections
Cancer
Musculoskeletal
Digestive system
Nervous system
Cardiovascular
Skin
Metabolic
Endocrine
Immune system
Cancer
Digestive system
Respiratory tract
Male
Female
Hemic and lymphatic
Immune system
Nervous system
Cancer
Digestive system
Respiratory tract
Otorhinolaryngologic
Nervous system
Hemic and lymphatic
Cardiovascular

Targets:

Proteases
GPCR
Ion Channels
Kinases

References: we are preparing a list of scientific research reports with L627-1099 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L627-1099?
Check Price and Availability of L627-1099, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.

What is the minimum amount of L627-1099 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.

Delivery options for L627-1099
ChemDiv sends parcels with Express services (UPS, WC).

1–2 days for small orders
2–4 weeks for large selections

Delivery formats for L627-1099

0.5–50 mg of dry powder sample in single glass vials, custom vials
DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L627-1099 available by request